Skip to main content

Personalis, Garvan Institute to Provide Genome Sequencing, Analysis to Researchers, Clinicians

NEW YORK (GenomeWeb) – Personalis and the Garvan Institute of Medical Research said today that they have partnered to provide commercial human whole-genome sequencing, analysis, and interpretation services to researchers and clinicians worldwide.

The partners will use the sequencing platform and expertise from the Garvan Institute, based in Sydney, Australia, and the pipeline, expertise, and infrastructure to analyze, annotate, and interpret the data from Personalis, located in Menlo Park, Calif.

The Garvan's Kinghorn Centre for Clinical Genomics recently purchased the HiSeq X Ten sequencing system from Illumina, allowing it to sequence more than 350 human genomes per week. The institute plans to undertake clinical research projects and ultimately to provide clinical-grade genome sequencing for diagnostic purposes.

"This agreement will accelerate the pace of scientific research and clinical diagnosis by facilitating rapid, comprehensive and accurate whole genome sequencing combined with high-quality analysis and easy-to-interpret reports for large projects involving human data," Personalis CEO John West said in a statement.

The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.